Irisin in metabolic diseases

SA Polyzos, AD Anastasilakis, ZA Efstathiadou… - Endocrine, 2018 - Springer
Introduction Irisin is a myokine/adipokine induced by the exercise in mice and humans,
which is proposed to induce “browning” of white adipose tissue, its primary target, thus …

Role of irisin in myocardial infarction, heart failure, and cardiac hypertrophy

MY Ho, CY Wang - Cells, 2021 - mdpi.com
Irisin is a myokine derived from the cleavage of fibronectin type III domain-containing 5. Irisin
regulates mitochondrial energy, glucose metabolism, fatty acid oxidation, and fat browning …

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT

X Zhang, C Hu, CY Kong, P Song, HM Wu… - Cell Death & …, 2020 - nature.com
Oxidative stress and cardiomyocyte apoptosis play critical roles in doxorubicin (DOX)-
induced cardiotoxicity. Previous studies indicated that fibronectin type III domain-containing …

Myokines and resistance training: a narrative review

BEM Zunner, NB Wachsmuth, ML Eckstein… - International journal of …, 2022 - mdpi.com
In the last few years, the muscular system has gained attention due to the discovery of the
muscle-secretome and its high potency for retaining or regaining health. These cytokines …

A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review

H Askari, SF Rajani, M Poorebrahim… - Pharmacological …, 2018 - Elsevier
Irisin is a hormone-like molecule mainly released by skeletal muscles in response to
exercise. Irisin induces browning of the white adipose tissue and has been shown to …

The emerging role of irisin in cardiovascular diseases

J Fu, F Li, Y Tang, L Cai, C Zeng, Y Yang… - Journal of the American …, 2021 - Am Heart Assoc
Irisin, a novel hormone like polypeptide, is cleaved and secreted by an unknown protease
from a membrane‐spanning protein, FNDC5 (fibronectin type III domain‐containing protein …

Myokines and heart failure: challenging role in adverse cardiac remodeling, myopathy, and clinical outcomes

AE Berezin, AA Berezin, M Lichtenauer - Disease Markers, 2021 - Wiley Online Library
Heart failure (HF) is a global medical problem that characterizes poor prognosis and high
economic burden for the health system and family of the HF patients. Although modern …

Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients …

S Yamada, K Tsuruya, T Kitazono, T Nakano - Clinical and Experimental …, 2022 - Springer
Chronic kidney disease–mineral and bone disorder (CKD–MBD) is a systemic disorder that
affects multiple organs and systems and increases the risk of morbidity and mortality in …

Irisin: a new code uncover the relationship of skeletal muscle and cardiovascular health during exercise

C Ma, H Ding, Y Deng, H Liu, X Xiong… - Frontiers in physiology, 2021 - frontiersin.org
Exercise not only produces beneficial effects on muscle itself via various molecular
pathways, but also mediates the interaction between muscles and other organs in an …

[HTML][HTML] Non-coding RNAs as biomarkers of myocardial infarction

H Almaghrbi, R Giordo, G Pintus, H Zayed - Clinica Chimica Acta, 2023 - Elsevier
Non-coding RNAs (ncRNAs) encompass a family of ubiquitous RNA molecules that lack
protein-coding potential and have tissue-specific expression. A significant body of evidence …